| Moderna, Inc.. (1/4/21). "Press Release: Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel". Cambridge, MA. |
2021-01-04 |
| Arvelle Therapeutics GmbH. (1/4/21). "Press Release: Angelini Pharma Acquires Arvelle Therapeutics to Create a Leading European Innovator in Central Nervous System (CNS) and Mental Health Disorder Treatments". Rome. |
2021-01-04 |
| Peptilogics. (12/21/20). "Press Release: Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform". Pittsburgh, PA. |
2020-12-21 |
| Atomwise, Inc.. (12/18/20). "Press Release: Atomwise and FutuRx Launch A2i Therapeutics – a New Immuno-Oncology Company Funded by Leading Biopharma VCs and the Israeli Innovation Authority". San Francisco, CA & Ness Ziona. |
2020-12-18 |
| MagForce AG. (12/15/20). "Press Release: MagForce AG Successfully Completes Private Placement of New Shares". Berlin & Nevada. |
2020-12-15 |
| Kaia Health Software GmbH. (11/30/20). "Press Release: Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets". Munich & Parma. |
2020-11-30 |
| Grifols S.A.. (11/24/20). "Press Release: Strategic Alliance between Grifols and the Egyptian Government to Boost Plasma-derived Medicines Self-sufficiency in the Middle East and Africa". Barcelona. |
2020-11-24 |
| Galapagos N.V.. (11/23/20). "Press Release: Selvita to Acquire Fidelta from Galapagos". Mechelen & Krakow. |
2020-11-23 |
| ATAI Life Sciences AG. (11/23/20). "Press Release: ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round". New York, NY. |
2020-11-23 |
| InSilicoTrials. (10/7/20). "Press Release: Blog Post – United Venture Is the Lead Investor in Our Round A". |
2020-10-07 |
| Sartorius AG. (10/2/20). "Press Release: Purification Specialist BIA Separations to Become Part of Sartorius". Göttingen. |
2020-10-02 |
| High-Tech Gründerfonds Management GmbH. (10/1/20). "Press Release: Neuromodulation Pioneer Wise Closes EUR 15M Series C Financing Round to Launch Second Product, SCS EXPERT, for Chronic Pain". |
2020-10-01 |
| Kymos S.L.. (9/28/20). "Press Release: Kymos and Prolytic Merge to Become Kymos Group". Barcelona & Frankfurt a.M.. |
2020-09-28 |
| Salvia BioElectronics B.V.. (9/22/20). "Press Release: Salvia BioElectronics Raises EUR 26M (USD 31M) to Develop Innovative Neurostimulation Therapy for Chronic Migraine". Eindhoven. |
2020-09-22 |
| Lonza Group Ltd.. (9/8/20). "Press Release: Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy Manufactured Using the Lonza Cell Immunotherapy Manufactured Using the Lonza Cocoon Platform". Basel & Tel Aviv. |
2020-09-08 |
| Algenex S.L.. (9/8/20). "Press Release: Algenex Raises €7.4 Million in Financing Round". Madrid. |
2020-09-08 |
| Grifols S.A.. (9/7/20). "Press Release: Grifols to Acquire Alkahest to Enhance Discovery Research and Development". Barcelona & San Carlos, CA. |
2020-09-07 |
| Genespire S.r.l.. (7/30/20). "Press Release: Genespire Appoints Jörn Aldag as Chairman of the Board of Directors". Milan. |
2020-07-30 |
| Enthera S.r.l.. (7/28/20). "Press Release: Enthera Pharmaceuticals Raises €28 Million in Series A Financing to Advance Restorative Therapy for Type 1 Diabetes and Inflammatory Bowel Disease". Milan. |
2020-07-28 |
| Coulter Partners. (7/28/20). "Press Release: Coulter Partners Secures Chief Executive Officer for Optimapharm". |
2020-07-28 |
| Optimapharm d.d.. (7/21/20). "Press Release: Optimapharm Appoints Dr. Andrew Copestake as Chief Executive Officer". |
2020-07-21 |
| Moderna, Inc.. (7/9/20). "Press Release: Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate". Cambridge, MA & Madrid. |
2020-07-09 |
| BIA Separations d.o.o.. (7/8/20). "Press Release: BIA Separations Signs Two New Distribution Agreements Extending Coverage in Asia Pacific". Ajdovšcina. |
2020-07-08 |
| VarmX B.V.. (7/8/20). "Press Release: VarmX Raises €32 million in Series B Financing to Develop Innovative Reversal Agent for the Treatment and Prevention of Severe Bleeding in Patients on Oral Anticoagulants". Leiden. |
2020-07-08 |
| Genespire S.r.l.. (6/30/20). "Press Release: Genespire and the San Raffaele Telethon Institute for Gene Therapy Announce Publication in Nature Biotechnology on Enhanced Gene Editing Technique in Hematopoietic Stem Cells". Milan. |
2020-06-30 |
| Ona Therapeutics. (6/16/20). "Press Release: Ona Therapeutics Raises €30m in Series A Financing". Barcelona. |
2020-06-16 |
| Epsilen Bio S.r.l.. (6/15/20). "Press Release: Epsilen Bio Appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board. Company Announces Strategic Collaboration with SR-Tiget". Milan. |
2020-06-15 |
| Ysios Capital. (6/10/20). "Press Release: Ysios Capital Presents Its Third Fund of € 200M". San Sebastián & Barcelona. |
2020-06-10 |
| Rigenerand S.r.l.. (6/2/20). "Press Release: Rigenerand Receives Regulatory Approval for Gene Therapy Production". Modena. |
2020-06-02 |
| Accure Therapeutics. (5/26/20). "Press Release: Accure Therapeutics Launches with €7.6M Series A Round". Barcelona. |
2020-05-26 |
| Genespire S.r.l.. (5/13/20). "Press Release: Genespire and SR-Tiget Announce Strategic Alliance for the Development of Transformative Gene Therapies for Genetic Diseases and Disclose Collaboration Focus". Milan. |
2020-05-13 |
| TRG Management LLP. (5/12/20). "Press Release: The Rohatyn Group Completes Investment in European Contract Research Organization, Optimapharm". New York, NY. |
2020-05-12 |
| ElsaLys Biotech S.A.S.. (5/7/20). "Press Release: Mediolanum Farmaceutici Acquires the French Company ElsaLys Biotech to Develop Next Generation Immuno-oncology Therapies". Milan. |
2020-05-07 |
| PinCell S.r.l.. (5/6/20). "Press Release: PinCell Appoints Veteran Biotech and Biopharma Executives to Management Team and Board of Directors. The Nominations Follow a Successful Seed Funding Led by Sofinnova Partners". Milan. |
2020-05-06 |
| Stemline Therapeutics, Inc.. (5/4/20). "Press Release: Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million". Florence & New York, NY. |
2020-05-04 |
| Genespire S.r.l.. (4/29/20). "Press Release: Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies. Biotech Executive, Julia Berretta, Ph.D., Is Named Chief Executive Officer". Milan. |
2020-04-29 |
| Sofinnova Partners. (4/20/20). "Press Release: Sofinnova Partners Announces Third Investment from its Italian Fund". Milan. |
2020-04-20 |
| LNC Therapeutics. (4/15/20). "Press Release: LNC Therapeutics Announces the Acquisition of an Exclusive Worldwide Licence on the First Patent related to Christensenella’s Therapeutic Applications in Mood Disorders". Bordeaux. |
2020-04-15 |
| MolMed S.p.A.. (4/14/20). "Press Release: MolMed: the Board of Directors, Based on the Scientific Evidence from the Experiments on Early-stage Pre-clinical Products, Decided to Suspend the Investments in These Projects". Milan. |
2020-04-14 |
| Izana Bioscience Ltd.. (4/6/20). "Press Release: Initiation of Two-centre Compassionate Use Study Involving Namilumab in the Treatment of Individual Patients with Rapidly Worsening COVID-19 Infection in Italy". Oxford. |
2020-04-06 |
| ERS Genomics Ltd.. (4/2/20). "Press Release: ERS Genomics and Axxam Announce CRISPR/Cas9 License Agreement to Enhance Discovery Services". Dublin & Milan. |
2020-04-02 |
| MolMed S.p.A. (at the request of AGC Inc.). (4/2/20). "Press Release: Offer Document Filed with Consob. Voluntary Public Tender Offer Launched by AGC Inc. on All the Ordinary Shares of MolMed S.p.A. [Not for release where violation of laws or regulations |
2020-04-02 |
| Biocat. (3/27/20). "Press Release: Barcelona to Host BIO-Europe Spring 2021". Barcelona. |
2020-03-27 |
| AGC Inc.. (3/17/20). "Press Release: AGC Decides to Launch Voluntary Tender Offer for Shares of MolMed". |
2020-03-17 |
| MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan. |
2020-03-09 |
| MolMed S.p.A.. (3/6/20). "Press Release: MolMed Signs a Multi-year Agreement and Announces the Beginning of a New Collaboration in the Field of T Cell Therapies". Milan. |
2020-03-06 |
| BIA Separations d.o.o.. (2/19/20). "Press Release: BIA Separations and University of Zagreb Sign License Agreement to Commercialize Novel Elution Method for Virus and Viral Vector purification". Ajdovšcina & zagreb. |
2020-02-19 |
| Grifols S.A.. (2/18/20). "Press Release: Grifols and the Public Investment Fund of Saudi Arabia Taking Steps to Boost Plasma Medicines Self-supply in the Region". Barcelona. |
2020-02-18 |
| PharmaMar S.A.. (2/17/20). "Press Release: PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer". Madrid & Dublin. |
2020-02-17 |
| Aurora-TT S.r.l.. (2/12/20). "Press Release: Rottapharm Biotech and Italfarmaco Team Up with AurorA-TT to launch AurorA Science". Milano. |
2020-02-12 |
| Osteolabs GmbH. (1/20/20). "Press Release: Osteolabs GmbH Successfully Closes First International Commercial Agreements and Starts Contract Research Collaboration with the Health Department of an European Army". Kiel. |
2020-01-20 |
| Almirall S.A.. (1/9/20). "Press Release: Almirall Signs a Strategic Agreement with 23andMe to License Rights of a Bispecific Monoclonal Antibody that Blocks All Three Isoforms of IL-36 Cytokine". Barcelona & Sunnyvale, CA. |
2020-01-09 |
| Almirall S.A.. (1/9/20). "Press Release: Almirall Enters into an Option Agreement to Acquire Bioniz Therapeutics and to Establish a Broad Research Agreement to Further Expand Its Innovative Pipeline in Medical Dermatology". Barcelona. |
2020-01-09 |
| Almirall S.A.. (1/9/20). "Press Release: Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases". Barcelona. |
2020-01-09 |
| Esteve Pharmaceuticals, S.A.. (1/8/20). "Press Release: Esteve Acquires German Proprietary, Specialty, Hospital-focused Company Riemser and Expands Its Presence in Europe". |
2020-01-08 |
| MolMed S.p.A.. (12/18/19). "Press Release: Italy – the EIB Supports MolMed Investment in Research, Development and Manufacturing for Cancer and Rare Diseases Innovative Treatments". Oxford. |
2019-12-18 |
| Bioncotech Therapeutics S.L.. (12/12/19). "Press Release: Bioncotech Therapeutics Phase I BO-112 Data Presented at ESMO Immuno-Oncology Congress 2019". Madrid. |
2019-12-12 |
| Bioncotech Therapeutics S.L.. (12/10/19). "Press Release: Bioncotech Therapeutics Announces Oncology Clinical Trial Collaboration with MSD. Phase II Trial with Combination of BO-112 and Pembrolizumab". Madrid. |
2019-12-10 |
| Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia. |
2019-11-27 |
| SP Industries, Inc.. (10/28/19). "Press Release: SP Acquires Spain Based i-Dositecno". Warminster, PA. |
2019-10-28 |
| Parc Cientific de Barcelona (BCP, Barcelona Science Park Foundation). (10/28/19). "Press Release: Molomics Opens an Investment Round to Accelerate an Innovative Project against Parkinson’s". Planegg & Mechelen. |
2019-10-28 |
| Evotec SE. (10/23/19). "Press Release: Evotec, Integra Holdings and Yissum Establish LAB555 to Fast Track Early-stage Drug Development". Hamburg. |
2019-10-23 |
| Kiadis Pharma N.V.. (10/22/19). "Press Release: Kiadis Pharma Announces Formation of Renowned Scientific Advisory Board". Amsterdam. |
2019-10-22 |
| Biocat. (10/21/19). "Press Release: Boehringer Ingelheim Joins the d·HEALTH Barcelona Program to Foster Innovation in Health". Barcelona. |
2019-10-21 |
| MolMed S.p.A.. (10/10/19). "Press Release: MolMed Informs on Its Decision to Withdraw the Conditional Marketing Authorization of Zalmoxis". Milan. |
2019-10-10 |
| Adaptimmune Ltd.. (9/30/19). "Press Release: Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO". Philadeliphia, PA & Oxfordshire. |
2019-09-30 |
| Innate Pharma S.A.. (9/23/19). "Press Release: Innate Pharma Announces Clinical Data Presentations on IPH5401 and Monalizumab at ESMO 2019". Marseille. |
2019-09-23 |
| Newron Pharmaceuticals S.p.A.. (9/20/19). "Press Release: Newron Pharmaceutical Commercialization Partner Meiji Seika together with Eisai Announce the Approval of Safinamide for Parkinson’s Disease in Japan". Milan. |
2019-09-20 |
| CRISPR Therapeutics AG. (9/17/19). "Press Release: CRISPR Therapeutics and ViaCyte Present Positive In Vitro Data Towards a Potential Immune-Evasive Cell Replacement Therapy for Diabetes at EASD 2019". Zug, Cambridge, MA & San Diego, CA. |
2019-09-17 |
| Genenta Science S.r.l.. (9/11/19). "Press Release: Genenta Science Announces 13.2 Million in a New Round of Financing, Hits a Total above 30 Million since Inception. Two Clinical Trials Ongoing.". Milano & New York, NY. |
2019-09-11 |
| Devicare S.L.. (9/5/19). "Press Release: The PREVENTLIT Study Shows that Lit-Control Reduces new Episodes of Renal Lithiasis in Patients". Cerdanyola del Vallès. |
2019-09-05 |
| Bruker Corporation. (8/26/19). "Press Release: Bruker Announces World's First 1.2 GHz High-Resolution Protein NMR Data". Berlin. |
2019-08-26 |
| SP Industries, Inc.. (8/13/19). "Press Release: SP Scientific Announces the Signing of New Partnership Agreement ith Lab-i-Dositecno Pharma Technologies". Warminster, PA. |
2019-08-13 |
| Grifols S.A.. (7/31/19). "Press Release: Grifols Increases Its Revenues by 14.3% to EUR 2,423 million, Driven by Its Strategic Growth Plan". Barcelona. |
2019-07-31 |
| Curetis N.V.. (7/30/19). "Press Release: Curetis and Ako Med Ink Distribution Agreement Covering Four Countries in CEE Region". Amsterdam, San Diego, CA & Holzgerlingen. |
2019-07-30 |
| Zambon Group. (7/25/19). "Press Release: Zambon Completes Transformational Acquisition of Breath Therapeutics". Milan. |
2019-07-25 |
| 3P Biopharmaceuticals S.L.. (7/23/19). "Press Release: 3P Biopharmaceuticals Welcomes Keensight Capital as Majority Shareholder". Paris. |
2019-07-23 |
| Keensight Capital. (7/23/19). "Press Release: Keensight Capital Acquires 3P Biopharmaceuticals to Accelerate Its Global Growth Strategy". Paris. |
2019-07-23 |
| ImCheck Therapeutics S.A.S.. (7/18/19). "Press Release: ImCheck Therapeutics Appoints Paul Frohna MD, PhD, PharmD, as Chief Medical Officer". Marseille. |
2019-07-18 |
| Arcis Biotechnology Ltd.. (7/16/19). "Press Release: Arcis Biotechnology and Mirnax Biosens Sign Exclusive License Agreement for Arcis Sample Prep Technology". Daresbury & Madrid. |
2019-07-16 |
| Kither Biotech S.r.l.. (7/5/19). "Press Release: Kither Biotech Raises a €5.6m Financing Round to Support the Clinical Development of a New Drug for Cystic Fibrosis and other Pulmonary Diseases". Turin. |
2019-07-05 |
| Illumina, Inc.. (6/28/19). "Press Release: Illumina Files Patent Infringement Suits Related to BGI in Switzerland, Turkey and the US". San Diego, CA. |
2019-06-28 |
| Laboratoris Sanifit S.L.. (6/26/19). "Press Release: Sanifit Announces €72.2M ($80.9M) Financing in Spain’s Largest Private Biotech Fundraise". Palma & San Diego, CA. |
2019-06-26 |
| Catalent, Inc.. (6/19/19). "Press Release: Catalent to Purchase Bristol-Myers Squibb Manufacturing Facility in Anagni, Italy". New York, NY & Somerset, NJ. |
2019-06-19 |
| Qiagen N.V.. (6/5/19). "Press Release: Qiagen and DiaSorin Collaborate on Novel QuantiFERON-based Test with Breakthrough Potential for Earlier Detection of Lyme Disease". Germantown, MD, Hilden & Saluggia. |
2019-06-05 |
| Spindiag GmbH. (6/4/19). "Press Release: Spindiag’s Continued Road to Success. Expansion of Series A with an additional 4 Million Euros for Market Entry". Freiburg. |
2019-06-04 |
| Galapagos N.V.. (5/29/19). "Press Release: Gilead and Galapagos to Present Latest Data on Filgotinib at the Annual European Congress of Rheumatology (EULAR 2019)". Foster City, CA & Mechelen. |
2019-05-29 |
| IRB Barcelona. (5/21/19). "Press Release: The IRB Barcelona Spin-off Ona Therapeutics Hits the Road Thanks to Sabadell Asabys". |
2019-05-21 |
| Philogen S.p.A.. (5/13/19). "Press Release: Philogen Announces €62 Million Financing Round". Siena. |
2019-05-13 |
| Pfizer Inc.. (5/7/19). "Press Release: European Commission Approves Lorviqua (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer". |
2019-05-07 |
| Symrise AG. (5/6/19). "Press Release: Symrise Acquires Italian Biotech Company Cutech. Adds Competitive Edge in Bio-analytical Methods – Expands R&D Capacities for the Efficacy Testing of Cosmetic Ingredients". |
2019-05-06 |
| Devicare S.L.. (5/3/19). "Press Release: Devicare Launches Lit-Control in the US with Diem Labs". |
2019-05-03 |
| Curetis N.V.. (4/11/19). "Press Release: Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019". Amsterdam & Holzgerlingen. |
2019-04-11 |
| Sophia Genetics S.A.. (4/11/19). "Press Release: Sophia Genetics Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection". Lausanne. |
2019-04-11 |
| Selvita S.A.. (3/28/19). "Press Release: Selvita to Separate Oncology Therapeutics and Contract Research Business Units into Two Global Companies". Krakow. |
2019-03-28 |
| Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London. |
2019-03-27 |
| Curetis N.V.. (3/26/19). "Press Release: Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero". Amsterdam & Holzgerlingen. |
2019-03-26 |
| PharmaMar S.A.. (3/25/19). "Press Release: PharmaMar Announces Positive Results in Its Lurbinectedin Monotherapy Trial for Small Cell Lung Cancer". Madrid. |
2019-03-25 |
| Cambrex Corporation. (3/14/19). "Press Release: Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan". East Rutherford, NJ. |
2019-03-14 |
| MolMed S.p.A.. (3/13/19). "Press Release: Partnership in the Field of Rare Genetic Diseases with Rocket Pharma Extended to Three New Therapeutic Indications". Milan. |
2019-03-13 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2019.png){kind=logo}
![Picture [iito] Männer Ballett 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-maenner-ballett.jpg)
Date![Picture [iito] Plain Stupid Simple 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-plain-stupid-simple.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
